Jörg Beyer

5PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2023
Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.

Jakob Lauritsen, Nicolas Sauvé, Alexey Tryakin

|Apr 06, 2021
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.

Silke Gillessen, Nicolas Sauvé, Laurence Collette

|Mar 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.

Jörg Beyer, Laurence Collette, Nicolas Sauvé

|Apr 11, 2019
Prognostic factors in metastatic germ-cell cancer.

J Beyer

|Jan 26, 2018
Response to first-line treatment and histology are associated with achieving complete remission after the first salvage high-dose chemotherapy in relapsing germ cell tumor patients.

Flavio Gössi, Martin Spahn, Panagiotis Samaras

Pageof 1

Frequent Collaborators

3 joint publications

Robert Huddart

3 joint publications

Michal Chovanec

3 joint publications

Christian Fankhauser

3 joint publications

Gedske Daugaard